legislation: 114-s-3387

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
114-s-3387 114 s 3387 SAVINGS Act Health 2016-09-22 2016-09-22 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Cotton, Tom [R-AR] AR R C001095 0 Safely Advancing Valuable and Inexpensive New Generic Solutions Act or the SAVINGS Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to prioritize the review of certain generic drug applications and act on them within 150 days. This generic fast track review applies to applications for drugs: (1) that are not under patent or for which patents will expire soon, (2) for which there is no marketing exclusivity in effect, and (3) for which a generic has not recently been introduced to the market by more than one manufacturer. The FDA must report on applications subject to generic fast track review and provide an annual accounting of how it has spent generic drug user fees. 2023-01-11T13:33:32Z  

Links from other tables